Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ

Clinical trial NCT06761846 · RECRUITING

Trial details

NCT number: NCT06761846
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophagogastric Junction Adenocarcinoma

Start date: 2025-01-17
Primary completion: 2027-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.